Wearable Skin Devices
Dermal sensors for continuous, clinical-grade monitoring.
Built around the business reality of your team.
The next decade of medicine is continuous, not episodic. Chronic disease, decentralised trials, and home-based care all depend on devices that patients will actually wear — and data that clinicians can actually trust. Future Trity's dermal sensor platform was built for both audiences.
Most wearables are wellness toys with clinical aspirations. We build the inverse: medical-grade devices engineered to ISO 13485 with consumer-grade comfort and adherence.
A method, not just a capability.
Skin-conformal electronics with multi-day wear comfort.
Edge analytics that preserve battery and protect patient data.
Validated against gold-standard clinical reference devices.
Open APIs for integration with EHRs and trial platforms.
Clear deliverables, audit-ready documentation.
Continuous Vital Signs
Heart rate, respiration, temperature, hydration, and SpO2 from a single patch.
Biochemical Sensing
Glucose, lactate, and electrolyte monitoring via interstitial fluid.
Decentralised Trial Kits
Patient onboarding, data capture, and adherence tooling for remote studies.
Custom Sensor Development
Co-engineered devices for proprietary endpoints and biomarkers.
The difference is in the discipline.
ISO 13485 Certified
Full medical device quality system, not a consumer-electronics shortcut.
Clinical Validation
Published agreement studies vs. reference standards across major endpoints.
Adherence-First Design
Average 5.8 day wear time — patients actually keep them on.
Integrated Data Platform
HIPAA and GDPR-compliant cloud with clinician dashboards out of the box.
Building a decentralised trial, chronic care program, or new clinical endpoint?
Our team responds within one business day with a tailored capability brief and next-step proposal.
Brief our Wearable Skin Devices team.
Submissions are reviewed by the capability lead within one business day. All information is treated as confidential under our standard Mutual NDA framework.
Capability lead acknowledges within 24 business hours with a reference number.
Mutual NDA executed prior to detailed technical exchange.
Scoping call with subject-matter experts and a written capability brief.